| INTRODUCTION
Influenza A viruses (IAV) cause severe public health problems with worldwide each year, among which the acute respiratory distress syndrome (ARDS) or acute lung injury (ALI) result in the majority of influenza pneumonia associated death. 1, 2 It is recorded that in 1918, approximately 50 million people lose their lives worldwide because of reoccurring pandemics. 3 The host target cells, such as epithelial cells, have an essential role in responding to the IAV infection. In addition to this, the responses of immune cells, especially the macrophages are also important. 4, 5 Airway macrophages (AMs) are among the first line of body defense upon the infection of IAV. The AMs have the ability to phagocytose virions and IAV-infected cell, and its infection symbolizes an early stage of virus recognition by the innate immune system. 6, 7 In addition to the early stage functions, macrophages were also found to modulate both the innate and adaptive immune responses at the late stages, 8 as well as to be essential antigen presenting cells. 9 The importance of its responses can be demonstrated by depletion of alveolar macrophages before IAV infection, which caused increased morbidity, mortality, and symptom severity. 10, 11 However, the overresponse of macrophages to IAV infection also results in pathogenesis. It has been reported that the tissue damage caused by macrophages contributes to the following bacterial infections, and ultimately causing morbidity and mortality. 12, 13 Inflammation is an adaptive physiological response following infection and tissue injuries. It is the results of series immune responses, and also leads to varieties of morbidities. Extensive studies showed that inflammation was correlated with altered signaling pathways, with enhanced levels of inflammatory markers, free radicals, and lipid peroxides. Inflammation has been hypothesized to play an essential role in competing infection and in wound healing. 14 Thus, restriction of macrophage inflammatory responses to IAV infection has important clinical significance.
Curcumin, the major curcuminoid of the turmeric, has multiple health-promoting biological activities. 15 Curcumin was first used as an anti-inflammatory agent since ancient times. Because of its antiapoptotic, anti-oxidative, and anti-inflammatory abilities, curcumin was then widely used for preventing or treating a variety of diseases other than inflammation. 16, 17 The anti-inflammatory properties of curcumin have been well studied. For example, it was reported that curcumin inhibited diverse signaling pathways, including NF-ĸB, cyclinD1, Cyclooxygenase-2 (COX-2), tumor necrosis factor alpha (TNF-α), signal transducer, and activator of transcription (STAT). 18 Jin et al. 19 found that curcumin inhibits interleukin 6 (IL-6) and TNF-α expression in lipopolysaccharide (LPS)-induced BV2 microglia cell. Cho and colleagues revealed that in TNF-α-treated HaCaT cells, curcumin reduced interleukin-1β (IL-1β) and IL-6 production via inhibiting NF-ĸB and mitogen-activated protein kinase (MAPK) signaling pathways. 20 In addition, the analogs of curcumin, such as B06 and C66, also have antiinflammatory ability through inhibiting NO and TNF-α production, and reducing mRNA expression of cytokines such as COX-2, IL-12, IL-6, TNF-κ, and IL-1β. 21, 22 Even the anti-inflammatory ability of curcumin was well investigated, its anti-IAV function studies are very limited.
Umar et al. 23 utilized turkeys to study the possible effects of curcumin on immuneresponse and pathogenesis of H9N2 avian influenza virus (AIV). They found that in cooperation with thymoquinone, curcumin could be able to dramatically improve the immune responses and restrain the pathogenesis of influenza viruses in turkeys.
In our present study, we aim to investigate whether curcumin can relieve the lung inflammation caused by IAV infection, and its possible mechanisms and therapeutic potential.
| METHODS

| Preparation and culture of human macrophages
The human mononuclear cells were separated from the peripheral 
| Measurements of cytokine levels by enzymelinked immunosorbent assay (ELISA)
ELISA kits (R&D Systems) were used for detection of TNF-α, interferon-alpha (IFN-α), and IL-6 levels in cell culture supernatant and mouse bronchoalveolar lavage fluid (BALF) according to the manufacturer's instructions.
| Western blots
Cells were gently re-suspended in 500 μL 1×Hypotonic Buffer by pipetting up and down several times, which was incubated on ice for 
| Animal treatment
The mice were provided by the Animal Center of Nanjing Medical University and were randomly set into seven groups. Eight mice were allocated in each experimental group. Mice from group one were without any treatment, while those from the other six group were exposed by intratracheal route to 2. 
| Analysis of inflammatory cells in BAL fluid
PBS was slowly implanted into the lungs of mice and then a cannula that had been inserted into the trachea was used to withdraw the liquid. Cells were harvested by centrifugation at 500 g for 7 minutes, and the supernatants were collected and stored at −80°C until needed. 
| Statistical analyzes
All the experiments data were statistically analyzed and performed using Prism software package (GraphPad Software, Version 5.00, San Diego, CA, USA). All the values are expressed as mean±SD.
The significance of differences between groups was analyzed by the one or two-way analysis of variance (ANOVA) followed by the Tukey-Kramer test.
| RESULTS
| Curcumin has no effects on macrophage viability and the percentage of IAV-infected human macrophages
As it has been known that macrophages play an essential role in IAV infection, 24 
| Curcumin treatment attenuates cytokine secretion in IAV-infected human macrophages
To further investigate the effect of curcumin on IAV-infected macrophages, we determined the secretion of the pro-inflammatory cytokines TNF-α, IFN-α, and IL-6, which contribute to the IAV-induced inflammation. We found that at the time point of 6-and 24-hour post-infection of IAV, secretion of these cytokines showed a curcumin dose-dependent decrease, compared with the control group which received no curcumin treatment (Figures 2A-C) . These results indicated that curcumin might have an anti-IAV ability. 
| Curcumin suppresses cytokine production in IAV-infected macrophages via downregulation of NF-κB signaling pathway
It has been reported that before IAV stimulation, p38 MAPK and extracellular signal-regulated kinases (ERK) were constitutively expressed and activated in macrophages. After IAV infection, the NF-κB inhibitor IκBα could be phosphorylated and degraded. 26 To further investigate the mechanisms involved in curcumin-regulated cytokine production of IAV-infected macrophages, we conducted P65 is a protein involved in NF-κB heterodimer formation, nuclear translocation, and activation. 27 It showed that IAV infection of macrophages leads to a significant decrease in cytosolic p65, while the levels of nuclear p65 increased under such condition. However, when the cells were treated with curcumin, we detected that both cytosolic p65
and nuclear p65 returned back to the resting levels ( Figure 3A and B).
Our results demonstrated that upon IAV infection, macrophages might be activated to secret inflammatory cytokines through activation of NF-κB signaling pathway, while the antivirus ability of curcumin might depend on inhibition of NF-κB in macrophages.
| Curcumin inhibited the in vivo expanding of immune cells and cytokine production in mice BAL fluid upon IAV infection
To determine whether curcumin affects immune cells, mice were ex- 
| DISCUSSION
The Previous studies have revealed that NF-κB signaling pathway is one of the most important pathways that are activated in macrophages under the pathogen challenge. [34] [35] [36] [37] [38] Thus, we aimed to study whether the anti-inflammatory ability of curcumin is associated with NF-κB signaling pathway. By examining the protein expression levels via Western Blotting, we found that IAV infection leads to the decrease in IκBα and cytosolic p65, while enhanced the levels of p-IκBα and nuclear p65. However, administration of curcumin exactly reversed this phenomenon. IκBα is a NF-κB inhibitor that could be phosphorylated and degraded when cells suffering IAV challenge. P65
is a component of NF-κB heterodimer, which is associated with NF-κB nuclear translocation and activation. 27 
